In the present study , we utilized RXR -and RAR -specific agonists and antagonists to determine how RA overcomes the dominant-negative activity of the truncated RARalpha in these different myeloid developmental stages .
in the present study , we utilized rxr -and rar -specific agonists and antagonists to determine how ra overcomes the dominant-negative activity of the truncated raralpha in these different myeloid developmental stages .
O O O O O O O B-protein_molecule O B-protein_family_or_group O B-other_organic_compound O B-other_organic_compound O O O B-other_organic_compound O O B-other_name I-other_name O O B-protein_family_or_group I-protein_family_or_group O O O B-other_name I-other_name I-other_name O